People with MS often need peer support, especially when disability is greater or MS is newer, but many do not take part even though it may help with feeling less lonely and better overall.
The study asked 218 people with MS in Ireland about peer support, social support, loneliness, and wellbeing. People who had more trouble with daily activities (higher disability) and those who had been diagnosed more recently said they needed peer support more. Fewer people actually attended peer support groups, whether online or in person. Going to in-person peer support was linked to a small improvement in wellbeing, but the link was weak. The strongest factors tied to feeling better were having less loneliness and more general social support from friends, family, or community.
People with MS should care because peer support can offer practical tips and emotional understanding from others who have similar experiences — like getting advice on managing fatigue from someone who’s tried the same strategies. Caregivers and family can use peer groups to learn how others manage day-to-day challenges, which can reduce stress at home, similar to trading recipes that actually work for a picky eater. Healthcare providers should know many patients want peer support but don’t join groups, so clinicians could suggest and help connect patients to suitable groups. Newer patients and those with greater disability may benefit most from being offered peer support proactively. Overall, joining peer support may help reduce loneliness and improve how supported someone feels, even if it is not a complete fix for wellbeing.
This study was a one-time survey, so it shows links but can’t prove that peer support causes better wellbeing. The improvement seen with in-person peer support was small, and other things like loneliness and general social support explained more of people’s wellbeing. Because the study was done in Ireland with 218 participants, results might look different in other countries or in larger groups.
12/31/2026
Learn how certain gut bacteria can worsen MS symptoms and what this means for treatment and daily li
Read More12/1/2026
Discover how the CEAM tool aids in understanding DNA changes in brain cells, offering hope for bette
Read More3/1/2026
Early OCT eye scans can often distinguish MOGAD from NMOSD optic neuritis, helping guide faster trea
Read More3/1/2026
Learn about the risks of enterovirus encephalitis for MS patients on ocrelizumab and how early recog
Read More3/1/2026
Learn how TREM2 helps brain immune cells switch to a repair mode, reduce inflammation, and may suppo
Read More3/1/2026
Discover how new research could help women with MS produce more IL-10, an important substance for co
Read MoreWhether you’ve recently been diagnosed with Multiple Sclerosis (MS) or are seeking to broaden your understanding of this complex, neurodegenerative disease, navigating the latest research can feel overwhelming. Studies published in respected medical journals like Journal of health psychology often range from early-stage, exploratory work to advanced clinical trials. These evidence-based findings help shape new disease-modifying therapies, guide symptom management techniques, and deepen our knowledge of MS progression.
However, not all research is created equal. Some clinical research studies may have smaller sample sizes, evolving methodologies, or limitations that warrant careful interpretation. For a more comprehensive, accurate understanding, we recommend reviewing the original source material—accessible via the More Details section above—and consulting with healthcare professionals who specialize in MS care.
By presenting a wide range of MS-focused studies—spanning cutting-edge treatments, emerging therapies, and established best practices—we aim to empower patients, caregivers, and clinicians to stay informed and make well-informed decisions when managing Multiple Sclerosis.